AVALO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 6, 2022, Avalo Therapeutics, Inc. released an updated investor
presentation (the "Investor Presentation"). The Investor Presentation will be
used from time to time in meetings with investors. A copy of the Investor
Presentation is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.

Also on January 6, 2022, the Company issued a press release announcing positive
Phase 1b Results for AVTX-002 in moderate to severe Crohn's disease patients and
additional program updates, a copy of which is attached as Exhibit 99.2 to this
Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits:

  Exhibit No.                                            Description

      99.1                Investor Presentation.

      99.2                Press Release, dated January 6, 2022.

      104               The cover pages of this Current Report on Form 8-K,

formatted in Inline XBRL.




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses